Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screening
Year: 2026
Type: article
Study design: Observational Study
Abstract: Cancer screening guidelines specify ages at which routine screening should be discontinued and, except for cervical cancer screening, do not require specific screening history criteria be met for discontinuation. We estimated the prevalence of being up to date with average-risk screening guidelines for colorectal, cervical, and lung cancer as of the recommended ages for discontinuation of routine screening. We conducted a descriptive study among several U.S. healthcare systems during 2010-2019. Up-to-date screening prevalence, based on U.S. Preventive Services Task Force guidelines, was ascertained prior to 76th, 66th, and 81st birthdays among persons eligible for colorectal (N = 316,756 persons), cervical (N = 20,282 persons), and lung cancer (N = 1,151 persons) screening, respectively. Up-to-date screening prevalence was 84.4% for colorectal, 58.9% for cervical, and 6.3% for lung cancer screening. Up-to-date screening prevalence at the ages recommended for discontinuing routine colorectal, cervical, and lung cancer screening varied appreciably, and was particularly low for lung cancer screening.
DOI: 10.1093/jnci/djag044
Institutions: Kaiser Permanente Washington Health Research Institute, Fred Hutch Cancer Center, University of Washington, Kaiser Permanente, Kaiser Permanente Northern California, Abramson Cancer Center, University of Pennsylvania, Rutgers, The State University of New Jersey, Washington University in St. Louis, Marshfield Clinic Research Foundation, Marshfield Clinic Research Institute, Henry Ford Health, National Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS), G2071538850, G2927523931, G3374432036, G4420091759, Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24), G5614079819, Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE), Assessing how multilevel factors shape disparities in cancer screening, Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations, G9000097163, G9000228396, G9000299868
OpenAlex ID: W7129063802